Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Howze YalondaCHIEF LEGAL OFFICER | Option exercise | M | — 335 sh | Jan 16, 2026 |
| 17 | Osterhout Jeannette EEVP & CFO | Grant or award | A | — 26.4K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 16 | Yeh Kuanling AmyChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $34K 3,000 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 16 | Gooden NathanDirector | Grant or award | A | $67K 6,667 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 16 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $280K 600 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 15 | Hsieh Anthony LiDirector, Executive Chair, CEO & Pres., 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.10M 415.5K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 15 | Oseland Robert LChief Operating Officer | Option exercise | M | — 125.0K sh | Jan 16, 2026 traded Jan 13, 2026 |
| 15 | Argen JohnDirector | Disposition to issuer | D | $297K 57.2K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 15 | Oseland Robert LChief Operating Officer | Option exercise | M | — 141.7K sh | Jan 16, 2026 traded Jan 13, 2026 |
| 15 | O'Kelly CiaranDirector | Grant or award | A | — 1,168 sh | Jan 16, 2026 traded Jan 12, 2026 |
| 14 | Choudary Kiran KumarChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $372K 5,427 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 14 | Wren ChrisVP of Operations | Open-market sale | SELL | $5,529 30.0K sh | Jan 16, 2026 traded Jan 16, 2026 |
| 14 | Choudary Kiran KumarChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $968K 14.4K sh | Jan 16, 2026 traded Jan 16, 2026 |
| 14 | Nithrakashyap ArvindDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $73K 1,045 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 13 | Howze YalondaCHIEF LEGAL OFFICER | Option exercise | M | — 335 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Option exercise · 10b5-1 plan | M | $513K 3,054 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Mercier MattCFO | Grant or award | A | — 6,896 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $73K 160 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $56K 120 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $145K 320 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Mercier MattCFO | Grant or award | A | — 6,896 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Disposition to issuer · 10b5-1 plan | D | $513K 2,454 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $108K 240 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $73K 160 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | D'Amico AndrewDirector | Open-market sale · 10b5-1 plan | SELL | $30K 200 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $186K 400 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Devaisher Len DPresident and COO | Grant or award | A | — 2,131 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Sims Gary LSVP & Chief Credit Officer | Grant or award | A | — 1,066 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Edekar Edmundson TinaDirector | Option exercise | M | $12K 616 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $168K 360 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Mahoney Robert JohnEVP Global Operations | Grant or award | A | — 1,734 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Lee JeannieEVP, GENERAL COUNSEL | Grant or award | A | — 4,598 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Lee JeannieEVP, GENERAL COUNSEL | Grant or award | A | — 4,598 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $110K 240 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Conrad Micah R.EVP & COO | Grant or award | A | — 31.5K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 12 | Narayan ShruthiPresident | Tax withholding | F | $100K 286 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 12 | Marathe AjayChief Operating Officer | Tax withholding | F | $66K 8,087 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 12 | Maglione Lawrence A.Director | Disposition to issuer | D | $129K 24.8K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 12 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Open-market sale · 10b5-1 plan | SELL | $209K 1,010 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 11 | Burroughs Amy L.Director, Chief Executive Officer | Grant or award · 10b5-1 plan | A | — 150.0K sh | Jan 16, 2026 traded Jan 14, 2026 |